Outcome of treatment in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia—results of the prospective multicenter LALA-94 trial
…, JM Cayuela, P Fenaux, JH Bourhis… - Blood, The Journal …, 2002 - ashpublications.org
From 1994 to 2000, 154 adults with Philadelphia chromosome–positive (Ph + ) and/orBCR-ABL
+ acute lymphoblastic leukemia (ALL) were treated according to a prospective trial (…
+ acute lymphoblastic leukemia (ALL) were treated according to a prospective trial (…
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete …
…, R Delarue, V Liso, S Mirto, G Leone, JH Bourhis… - Blood, 2003 - ashpublications.org
In the European Organization for Research and Treatment of Cancer Leukemia Group and
Gruppo Italiano Malattie Ematologiche dell' Adulto (EORTC-LG/GIMEMA) acute myeloid …
Gruppo Italiano Malattie Ematologiche dell' Adulto (EORTC-LG/GIMEMA) acute myeloid …
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe …
D Blaise, M Kuentz, C Fortanier, JH Bourhis… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: To compare hematologic recovery in patients receiving allogeneic blood cell
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT). …
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT). …
Allogeneic marrow stem-cell transplantation from human leukocyte antigen–identical siblings versus human leukocyte antigen–allelic–matched unrelated donors (10 …
…, A Buzyn, N Gratecos, JY Cahn, JH Bourhis… - Journal of clinical …, 2006 - ascopubs.org
Purpose To investigate the influence of donor type (human leukocyte antigen [HLA] -identical
sibling donor versus HLA-A–, HLA-B–, HLA-Cw–, HLA-DRB1–, and HLA-DQB1–identical …
sibling donor versus HLA-A–, HLA-B–, HLA-Cw–, HLA-DRB1–, and HLA-DQB1–identical …
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
…, S Nguyen, V Coiteux, JH Bourhis… - Blood, The Journal …, 2015 - ashpublications.org
Because a pediatric-inspired Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
protocol yielded a markedly improved outcome in adults with Philadelphia …
protocol yielded a markedly improved outcome in adults with Philadelphia …
Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 …
…, E Raffoux, C Gardin, S Corm, JH Bourhis… - Journal of clinical …, 2010 - ascopubs.org
Purpose In patients with acute myeloid leukemia (AML), induction chemotherapy is based
on standard doses of anthracyclines and cytarabine. High doses of cytarabine have been …
on standard doses of anthracyclines and cytarabine. High doses of cytarabine have been …
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
N Vey, JH Bourhis, N Boissel… - Blood, The Journal …, 2012 - ashpublications.org
IPH2101 is an anti-killer inhibitory receptor (anti-KIR) mAb that can block KIR-mediated
inhibition of natural killer (NK) cells to enhance cytotoxicity against acute myeloid leukemia blasts…
inhibition of natural killer (NK) cells to enhance cytotoxicity against acute myeloid leukemia blasts…
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter …
…, C Pautas, O Reman, JH Bourhis… - Blood, The Journal …, 2007 - ashpublications.org
In elderly patients with acute myeloid leukemia (AML) treated intensively, no best postremission
strategy has emerged yet. This clinical trial enrolled 416 patients with AML aged 65 …
strategy has emerged yet. This clinical trial enrolled 416 patients with AML aged 65 …
Treatment with Piperacillin-Tazobactam and False-Positive Aspergillus Galactomannan Antigen Test Results for Patients with Hematological Malignancies
…, A Aupérin, F Wilquin, JH Bourhis… - Clinical infectious …, 2004 - academic.oup.com
We report the occurrence of a high rate of false-positive test results during the surveillance
of hematology patients for galactomannan (GM) antigenemia. Among 218 patients surveyed …
of hematology patients for galactomannan (GM) antigenemia. Among 218 patients surveyed …
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
…, M Kuentz, M Michallet, JH Bourhis… - Blood, The Journal …, 2002 - ashpublications.org
The use of peripheral blood stem cells (PBSCs) is rapidly growing in the allogeneic
transplantation setting as an alternative to bone marrow (BM). We previously reported a higher …
transplantation setting as an alternative to bone marrow (BM). We previously reported a higher …